These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 25659076
1. Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease. Doyon A, Fischer DC, Bayazit AK, Canpolat N, Duzova A, Sözeri B, Bacchetta J, Balat A, Büscher A, Candan C, Cakar N, Donmez O, Dusek J, Heckel M, Klaus G, Mir S, Özcelik G, Sever L, Shroff R, Vidal E, Wühl E, Gondan M, Melk A, Querfeld U, Haffner D, Schaefer F, 4C Study Consortium. PLoS One; 2015; 10(2):e0113482. PubMed ID: 25659076 [Abstract] [Full Text] [Related]
2. Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase. Fischer DC, Mischek A, Wolf S, Rahn A, Salweski B, Kundt G, Haffner D. Ann Clin Biochem; 2012 Nov; 49(Pt 6):546-53. PubMed ID: 22984195 [Abstract] [Full Text] [Related]
8. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease]. Milovanova LY, Milovanov YS, Kudryavtseva DV, Markina MM, Milovanova SY, Kozlovskaya LV, Lebedeva MV, Beketov VD, Moiseev SV, Mukhin NA, Fomin VV, Svistunov AA. Ter Arkh; 2015 Jan; 87(6):10-16. PubMed ID: 26281189 [Abstract] [Full Text] [Related]
9. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers . Lima F, Mawad H, El-Husseini AA, Davenport DL, Malluche HH. Clin Nephrol; 2019 Apr; 91(4):222-230. PubMed ID: 30862350 [Abstract] [Full Text] [Related]
10. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis. Yamada S, Tsuruya K, Yoshida H, Taniguchi M, Haruyama N, Tanaka S, Eriguchi M, Nakano T, Kitazono T. Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546 [Abstract] [Full Text] [Related]
13. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease. Chen H, Cui Y, Xing C, Purrunsing Y, Zha X, Shen C, Zeng M, Yang G, Yu X, Zhang L, Jiang Y, Shen Z, Ma H, Yin C, Li Y, Wang N. Int Urol Nephrol; 2018 Dec; 50(12):2279-2288. PubMed ID: 30361964 [Abstract] [Full Text] [Related]
17. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients. Bielesz BO, Hecking M, Plischke M, Cejka D, Kieweg H, Haas M, Marculescu R, Hörl WH, Bieglmayer C, Sunder-Plassmann G. Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265 [Abstract] [Full Text] [Related]
20. Influence of Parathyroidectomy on Bone Metabolism and Bone Pain in Patients with Secondary Hyperparathyroidism. Schneider R, Steinmetz C, Karakas E, Bartsch DK, Schlosser K. Eur Surg Res; 2018 Sep; 59(1-2):35-47. PubMed ID: 29393259 [Abstract] [Full Text] [Related] Page: [Next] [New Search]